Top stories in health and medicine, June 30, 2014

From MedPage Today: FDA Finally OKs Inhaled Insulin. After several denials, the FDA announced Friday that it had approved inhaled insulin (Afrezza) to be used for improving glycemic control in adult patients with diabetes. ADHD Meds Tied to Cardio Risk. Danish children taking stimulant drugs for attention deficit-hyperactivity disorder (ADHD) had roughly double the risk for cardiovascular problems compared with other ADHD kids, a large registry study found, although the absolute incidence was still very low. Diabetes Drug Denials Bad for Care? Endocrinologists are concerned that recent decisions by insurers to stop covering certain diabetic medications could have an impact on glycemic control. Soda Ban Bust Called Setback Not Defeat. Public health advocates aren’t discouraged by a New York court’s decision to put the cap back on former Mayor Bloomberg’s super-sized soda ban. Your patients are rating you online: How to respond. Manage your online reputation: A social media guide. Find out how.
Source: Kevin, M.D. - Medical Weblog - Category: Journals (General) Authors: Tags: News ADHD Diabetes Endocrinology Heart Source Type: blogs